Clinical Trials Logo

Acute Poisoning clinical trials

View clinical trials related to Acute Poisoning.

Filter by:
  • None
  • Page 1

NCT ID: NCT06316362 Completed - Acute Poisoning Clinical Trials

Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine

Start date: January 1, 2022
Phase: Phase 2
Study type: Interventional

The goal of the current study was to evaluate whether SMOF lipid administration could be used as an adjuvant therapy to treat acute, moderate-to-severe carbamazepine poisoning.

NCT ID: NCT05185570 Not yet recruiting - Acute Poisoning Clinical Trials

Prognosis of Elderly Patients With Acute Poisoning.

Start date: January 2022
Phase:
Study type: Observational

Acute poisoning is a major public health problem all over the world, it causes significant mortality and morbidity. It primarily involves younger populations, with less than 3% of the affected cases being in people aged 60 years or older in most studies. More than half of the intoxication events in the elderly over 65 years old were accidental.

NCT ID: NCT05148611 Not yet recruiting - Acute Poisoning Clinical Trials

Application Registration Study of ILE in Patients With Acute Poisoning

ILE
Start date: November 30, 2021
Phase:
Study type: Observational [Patient Registry]

In this study, the investigators aimed to study the effect of ILE in the treatment of acute fat-soluble substance poisoning,to further clarify the relevant mechanism of ILE in the treatment of fat-soluble drug poisoning,to standardize the relevant procedures of ILE detoxification treatment and further explore the adverse reactions and coping strategies of ILE treatment.

NCT ID: NCT00780078 Completed - Heart Failure Clinical Trials

Clinical Evaluation of Swallowing Disorders as a Predictor of Extubation Failure

EVAKIN
Start date: October 2008
Phase: N/A
Study type: Observational

Patients with failed extubation stay significantly longer in an intensive care unit (ICU) and have a higher mortality rate, than those intubated successfully. Reintubation is associated with life-threatening complications and a poor prognosis. Functional respiratory tests are frequently used as weaning parameters, however, they are not accurate enough to predict extubation failure. The incidence of swallowing dysfunction is underestimated, mainly among patients whose intubation lasts longer than 48 h.We previously observed that the assessment of the swallowing function and oropharyngeal motricity, conducted by the physiotherapist before extubation could be helpful for making decisions to extubate patients intubated for over 6 days. The objective of this study is to validate a scale previously devised and used for physiotherapist bedside evaluation of the swallowing function and oropharyngeal motricity, among patients intubated for over 6 days, to determine whether this scale is a good predictor of airway secretion-related extubation failure.Expected results : to validate a scale previously devised called " physiotherapist evaluation of the swallowing function and oropharyngeal motricity before extubation" by the mean of a multicentric study. In our hypothesis the clinical parameters studied could be predictive of extubation failure. Then, this evaluation could help the medical decision in the choice of the good time for extubation. The final objective is to lower the mortality related to extubation failure.